Janet carried out pre-registration with Sterling Winthrop and was appointed to the role of formulation scientist working on tablets, capsules and oral liquids. She then studied for PhD at University of Strathclyde in pharmaceutics in the formulation of metered dose inhaler suspensions in conjunction with Glaxo Welcome.

Janet joined CT as a bench formulation scientist where she worked on solid dosage forms initially, transferring over to work on hydrogels and was intimately involved in scale up and process development for Cervidil, having overall responsibility for manufacturing the launch supplies. Janet was involved in FDA audits and partnership visits with Forest, Ferring and Zeneca and has since worked on development projects both in partnership with other companies (Fisons, PowderJect, Britannia,) on powders and hydrogel projects and on CT led hydrogel projects. Janet is responsible for directing work leading to new IP on transmucosal delivery, new polymers and new loading approaches and also involved in examining both 'in licensing' and 'out licensing ' opportunities.

Janet is a past Chairperson of the local branch of the Professional Body of the Royal Pharmaceutical Society and a past presenter at British Pharmaceutical Conference, Controlled Release Society meetings, BIO2002, BIA Thistle conference 2003 and Department of Trade and Industry conference 2004.

Janet is currently an elected member of RPSGB Industrial Pharmacist Group committee and a Member of the Academy of Pharmaceutical Sciences and Controlled Release Society.

You can contact Dr Halliday at the following e-mail address.
janet.halliday@ctscotland.com
(back)